BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ribbons KA, Thompson JH, Liu X, Pennline K, Clark DA, Miller MJ. Anti-inflammatory properties of interleukin-10 administration in hapten-induced colitis. Eur J Pharmacol 1997;323:245-54. [PMID: 9128846 DOI: 10.1016/s0014-2999(97)00017-4] [Cited by in Crossref: 51] [Cited by in F6Publishing: 54] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Voitalov I, Zhang L, Kilpatrick C, Withers JB, Saleh A, Akmaev VR, Ghiassian SD. The module triad: a novel network biology approach to utilize patients' multi-omics data for target discovery in ulcerative colitis. Sci Rep 2022;12:21685. [PMID: 36522454 DOI: 10.1038/s41598-022-26276-x] [Reference Citation Analysis]
2 Cao Q, Mertens RT, Sivanathan KN, Cai X, Xiao P. Macrophage orchestration of epithelial and stromal cell homeostasis in the intestine. J Leukoc Biol 2022. [PMID: 35593111 DOI: 10.1002/JLB.3RU0322-176R] [Reference Citation Analysis]
3 Upadhyay G, Tiwari N, Maurya H, Upadhyay J, Joshi R, Ansari MN. In vivo wound-healing and antioxidant activity of aqueous extract of Roylea elegans leaves against physically induced burn model in Wistar albino rats. 3 Biotech 2021;11:442. [PMID: 34631343 DOI: 10.1007/s13205-021-02993-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Hodoodi F, Allah-Tavakoli M, Tajik F, Fatemi I, Moghadam Ahmadi A. The effect of head cooling and remote ischemic conditioning on patients with traumatic brain injury. iScience 2021;24:102472. [PMID: 34169235 DOI: 10.1016/j.isci.2021.102472] [Reference Citation Analysis]
5 Bian X, Wu W, Yang L, Lv L, Wang Q, Li Y, Ye J, Fang D, Wu J, Jiang X, Shi D, Li L. Administration of Akkermansia muciniphila Ameliorates Dextran Sulfate Sodium-Induced Ulcerative Colitis in Mice. Front Microbiol 2019;10:2259. [PMID: 31632373 DOI: 10.3389/fmicb.2019.02259] [Cited by in Crossref: 184] [Cited by in F6Publishing: 196] [Article Influence: 46.0] [Reference Citation Analysis]
6 Joo M, Kim HS, Kwon TH, Palikhe A, Zaw TS, Jeong JH, Sohn UD. Anti-inflammatory Effects of Flavonoids on TNBS-induced Colitis of Rats. Korean J Physiol Pharmacol. 2015;19:43-50. [PMID: 25605996 DOI: 10.4196/kjpp.2015.19.1.43] [Cited by in Crossref: 23] [Cited by in F6Publishing: 27] [Article Influence: 2.6] [Reference Citation Analysis]
7 Wang T, Zhou YT, Chen XN, Zhu AX, Wu BH. Remote ischemic postconditioning protects against gastric mucosal lesions in rats. World J Gastroenterol 2014; 20(28): 9519-9527 [PMID: 25071347 DOI: 10.3748/wjg.v20.i28.9519] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
8 Marlow GJ, van Gent D, Ferguson LR. Why interleukin-10 supplementation does not work in Crohn’s disease patients. World J Gastroenterol 2013; 19(25): 3931-3941 [PMID: 23840137 DOI: 10.3748/wjg.v19.i25.3931] [Cited by in CrossRef: 103] [Cited by in F6Publishing: 104] [Article Influence: 10.3] [Reference Citation Analysis]
9 Fan YM, Zhang LF, Zhao Y, Chen LL. Significance of RhoC and IQGAP1 expression in hepatocellular carcinoma. Shijie Huaren Xiaohua Zazhi 2011; 19(27): 2841-2845 [DOI: 10.11569/wcjd.v19.i27.2841] [Reference Citation Analysis]
10 Gu QP, Xie JF, Chen J, Zhang Y, Hong K, Bai AP. Treatment of murine colitis with IL-10-secreting Escherichia coliShijie Huaren Xiaohua Zazhi 2011; 19(27): 2835-2840 [DOI: 10.11569/wcjd.v19.i27.2835] [Reference Citation Analysis]
11 Whittle BJ, Varga C, Pósa A, Molnár A, Collin M, Thiemermann C. Reduction of experimental colitis in the rat by inhibitors of glycogen synthase kinase-3beta. Br J Pharmacol. 2006;147:575-582. [PMID: 16314851 DOI: 10.1038/sj.bjp.0706509] [Cited by in Crossref: 80] [Cited by in F6Publishing: 83] [Article Influence: 4.7] [Reference Citation Analysis]
12 Eamlamnam K, Patumraj S, Visedopas N, Thong-Ngam D. Effects of Aloe vera and sucralfate on gastric microcirculatory changes, cytokine levels and gastric ulcer healing in rats. World J Gastroenterol 2006; 12(13): 2034-2039 [PMID: 16610053 DOI: 10.3748/wjg.v12.i13.2034] [Cited by in CrossRef: 70] [Cited by in F6Publishing: 76] [Article Influence: 4.1] [Reference Citation Analysis]
13 Sasaki M, Mathis JM, Jennings MH, Jordan P, Wang Y, Ando T, Joh T, Alexander JS. Reversal of experimental colitis disease activity in mice following administration of an adenoviral IL-10 vector. J Inflamm (Lond). 2005;2:13. [PMID: 16259632 DOI: 10.1186/1476-9255-2-13] [Cited by in Crossref: 39] [Cited by in F6Publishing: 44] [Article Influence: 2.2] [Reference Citation Analysis]
14 Lindsay JO, Sandison A, Cohen P, Brennan FM, Hodgson HJ. IL-10 gene therapy is therapeutic for dextran sodium sulfate-induced murine colitis. Dig Dis Sci 2004;49:1327-34. [PMID: 15387364 DOI: 10.1023/b:ddas.0000037830.22065.71] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 1.6] [Reference Citation Analysis]
15 Naito Y, Takagi T, Yoshikawa T. Heme oxygenase-1: a new therapeutic target for inflammatory bowel disease. Aliment Pharmacol Ther 2004;20 Suppl 1:177-84. [PMID: 15298625 DOI: 10.1111/j.1365-2036.2004.01992.x] [Cited by in Crossref: 77] [Cited by in F6Publishing: 69] [Article Influence: 4.1] [Reference Citation Analysis]
16 Castagliuolo I, Brun P, Tormen D, Palò G. Lymphocytes endowed with colon-selective homing and engineered to produce TGF-beta1 prevent the development of dinitrobenzene sulphonic acid colitis. Eur J Gastroenterol Hepatol 2003;15:1257-65. [PMID: 14624147 DOI: 10.1097/00042737-200312000-00002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
17 Sasaki M, Jordan P, Houghton J, Meng X, Itoh M, Joh T, Alexander JS. Transfection of IL-10 expression vectors into endothelial cultures attenuates alpha4beta7-dependent lymphocyte adhesion mediated by MAdCAM-1. BMC Gastroenterol. 2003;3:3. [PMID: 12625840 DOI: 10.1186/1471-230x-3-3] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 0.7] [Reference Citation Analysis]
18 Van Montfrans C, Rodriguez Pena MS, Pronk I, Ten Kate FJ, Te Velde AA, Van Deventer SJ. Prevention of colitis by interleukin 10-transduced T lymphocytes in the SCID mice transfer model. Gastroenterology 2002;123:1865-76. [PMID: 12454844 DOI: 10.1053/gast.2002.37067] [Cited by in Crossref: 53] [Cited by in F6Publishing: 58] [Article Influence: 2.5] [Reference Citation Analysis]
19 Madsen K. Combining T cells and IL-10: a new therapy for Crohn's disease? Gastroenterology 2002;123:2140-4. [PMID: 12454869 DOI: 10.1053/gast.2002.37289] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 0.6] [Reference Citation Analysis]
20 Togawa J, Nagase H, Tanaka K, Inamori M, Nakajima A, Ueno N, Saito T, Sekihara H. Oral administration of lactoferrin reduces colitis in rats via modulation of the immune system and correction of cytokine imbalance. J Gastroenterol Hepatol 2002;17:1291-8. [PMID: 12423274 DOI: 10.1046/j.1440-1746.2002.02868.x] [Cited by in Crossref: 86] [Cited by in F6Publishing: 87] [Article Influence: 4.1] [Reference Citation Analysis]
21 Lindsay JO, Hodgson HJ. Review article: the immunoregulatory cytokine interleukin-10--a therapy for Crohn's disease? Aliment Pharmacol Ther 2001;15:1709-16. [PMID: 11683684 DOI: 10.1046/j.1365-2036.2001.01093.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 1.7] [Reference Citation Analysis]
22 Barbara G, Xing Z, Hogaboam CM, Gauldie J, Collins SM. Interleukin 10 gene transfer prevents experimental colitis in rats. Gut 2000;46:344-9. [PMID: 10673295 DOI: 10.1136/gut.46.3.344] [Cited by in Crossref: 107] [Cited by in F6Publishing: 105] [Article Influence: 4.7] [Reference Citation Analysis]
23 Peterson TC, Cleary CE, Shaw AM, Malatjalian DA, Veldhuyzen van Zanten SJ. Therapeutic role for bismuth compounds in TNBS-induced colitis in the rat. Dig Dis Sci 2000;45:466-73. [PMID: 10749319 DOI: 10.1023/a:1005476619923] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
24 Miller MJS. Gut Inflammation: is there a role for herbal medicines? Trends in Inflammatory Bowel Disease Therapy 1999 2000. [DOI: 10.1007/978-94-011-4002-7_20] [Reference Citation Analysis]
25 Stallmach A, Wittig B, Giese T, Pfister K, Hoffmann JC, Bulfone-Paus S, Kunzendorf U, Meuer SC, Zeitz M. Protection of trinitrobenzene sulfonic acid-induced colitis by an interleukin 2-IgG2b fusion protein in mice. Gastroenterology 1999;117:866-76. [PMID: 10500069 DOI: 10.1016/s0016-5085(99)70345-8] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 1.1] [Reference Citation Analysis]
26 Wallace JL, Vergnolle N, Muscará MN, Asfaha S, Chapman K, McKnight W, Del Soldato P, Morelli A, Fiorucci S. Enhanced anti-inflammatory effects of a nitric oxide-releasing derivative of mesalamine in rats. Gastroenterology 1999;117:557-66. [PMID: 10464131 DOI: 10.1016/s0016-5085(99)70448-8] [Cited by in Crossref: 67] [Cited by in F6Publishing: 68] [Article Influence: 2.8] [Reference Citation Analysis]
27 Morise Z, Eppihimer M, Granger DN, Anderson DC, Grisham MB. Effects of lipopolysaccharide on endothelial cell adhesion molecule expression in interleukin-10 deficient mice. Inflammation 1999;23:99-110. [PMID: 10213266 DOI: 10.1023/a:1020232826906] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 0.9] [Reference Citation Analysis]
28 Lamrani A, Tulliez M, Chauvelot-Moachon L, Chaussade S, Mauprivez C, Hagnéré AM, Vidon N. Effects of octreotide treatment on early TNF-alpha production and localization in experimental chronic colitis. Aliment Pharmacol Ther 1999;13:583-94. [PMID: 10233181 DOI: 10.1046/j.1365-2036.1999.00515.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
29 Higgins LM, Mcdonald SAC, Whittle N, Crockett N, Shields JG, Macdonald TT. Regulation of T Cell Activation In Vitro and In Vivo by Targeting the OX40-OX40 Ligand Interaction: Amelioration of Ongoing Inflammatory Bowel Disease with an OX40-IgG Fusion Protein, But Not with an OX40 Ligand-IgG Fusion Protein. The Journal of Immunology 1999;162:486-493. [DOI: 10.4049/jimmunol.162.1.486] [Cited by in Crossref: 6] [Article Influence: 0.3] [Reference Citation Analysis]